Jin Gyoung Jung

Cheongju University — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index763citations33works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Animal Genetics and Reproduction(9), Cancer, Hypoxia, and Metabolism(8), CRISPR and Genetic Engineering(5), Epigenetics and DNA Methylation(4), Diet and metabolism studies(4)

Publications33 total

785-P: Preclinical Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Assessments of Sustained-Released Formulation of Once-Monthly Injectable Semaglutide (PT403)
Diabetes·2024· 1 cited
781-P: Sustained-Release Formulation Development and Preclinical Evaluations of Monthly or Bimonthly Injectable Semaglutide and Tirzepatide
Diabetes·2023· 1 cited
Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy
iScience·2021· 22 citedOpen Access
641-P: Novel Microsphere Formulation Developments of Long-Acting GLP-1 RA Including Exenatide, Liraglutide, and Semaglutide
Diabetes·2021· 2 cited
Uncovering metabolic reservoir cycles in MYC-transformed lymphoma B cells using stable isotope resolved metabolomics
Analytical Biochemistry·2021· 7 citedOpen Access
Development of Small Molecule Inhibitors Targeting PBX1 Transcription Signaling as a Novel Cancer Therapeutic Strategy
2021· 1 citedOpen Access
Targeting Metabolic Cross Talk Between Cancer Cells and Cancer-Associated Fibroblasts
Advances in experimental medicine and biology·2021· 25 citedOpen Access
Development of Small Molecule Inhibitors Targeting PBX1 Transcription Signaling as a Novel Cancer Therapeutic Strategy
SSRN Electronic Journal·2021Open Access
Metabolism of Immune Cells in the Tumor Microenvironment
Advances in experimental medicine and biology·2021· 14 citedOpen Access
Abstract 6530: Old target, but new approach: Targeting cancer-associated MUC1 with ADC and Car-T
Cancer Research·2020· 1 cited
Front Cover: Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
PROTEOMICS·2019· 2 citedOpen Access
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
PROTEOMICS·2019· 63 citedOpen Access
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
Cell Reports·2019· 100 citedOpen Access
Abstract 1966: A novel small-molecule compound targeting PBX1-DNA interaction impedes cancer cell survival and carboplatin resistance
Cancer Research·2018
Abstract 5473: Identification of compensatory pathway for glutamate production upon glutaminase 1 inhibition
Cancer Research·2018
Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts
Advances in experimental medicine and biology·2018· 32 citedOpen Access
Abstract B15: Targeting PBX1 signaling to sensitize carboplatin cytotoxicity in ovarian cancer
Clinical Cancer Research·2015· 2 cited
Notch3 Interactome Analysis Identified WWP2 as a Negative Regulator of Notch3 Signaling in Ovarian Cancer
PLoS Genetics·2014· 91 citedOpen Access
Histological studies and lectin-binding assay in the chicken oviduct
한국가금학회 정기총회 및 학술발표회·2011
Characterization and Application of Oviductal Epithelial Cells In Vitro in Gallus domesticus1
Biology of Reproduction·2011· 34 cited
page 1 of 2Next →

Frequent Co-authors

Jae Yong Han(10), Anne Le(8), Tae Sub Park(8), Jeong Mook Lim(6), Yao Shen(5), Ie−Ming Shih(5), Tian‐Li Wang(5), Addison Quinones(4), Giang Hoang(4), Young‐Mock Lee(4), Jin Nam Kim(4), Beom Ku Han(4), Yohan Suryo Rahmanto(4), Chi‐Mu Chuang(4), Tu Nguyen(3), Ryoichi Asaka(3), Sunag Udupa(3), Amira Elgogary(3), Tae Min Kim(3), Cissy Zhang(3)